Morgan Keegan left its VCA Antech WOOF $18 price target and Market Perform rating unchanged in a research report published today.
In the report, Morgan Keegan states, "Long term we expect VCA Antech to maintain strong internal growth for its scalable veterinary lab business and internal growth augmented by accretive acquisitions for its animal hospitals. We believe that veterinary services are underpenetrated, providing the company with long-term growth opportunities. The weak economy creates a near-term impediment to growth prospects."
Shares of VCA Antech were at $23.10 in after hours trading, up 0.35% from Friday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in